Back
Aurinia Pharmaceuticals Vs. Acasti Pharma Industry Stock Comparison
Sell
42
AUPH
Aurinia Pharmaceuticals
Last Price:
5.61
Seasonality Move:
-3.04%
Sell
40
ACST
Acasti Pharma
Last Price:
2.88
Seasonality Move:
0.26%
Sell
42
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy, Sell or Hold?
- The current Aurinia Pharmaceuticals [AUPH] share price is $5.47. The Score for AUPH is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
- AUPH is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Acasti Pharma (ACST)
is a Sell
Is Acasti Pharma a Buy, Sell or Hold?
- The current Acasti Pharma [ACST] share price is $2.90. The Score for ACST is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- ACST is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
AUPH Stock Price Chart
What is Aurinia Pharmaceuticals's stock price today?
-
The Aurinia Pharmaceuticals share price today is $5.47
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and AUPH is experiencing slight buying pressure.
ACST Stock Price Chart
What is Acasti Pharma's stock price today?
-
The Acasti Pharma share price today is $2.90
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and ACST is experiencing slight selling pressure.
AUPH Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.05 | Buy |
Relative Strength Index (14 RSI): | 50.15 | Buy |
Chaikin Money Flow: | 99868 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (5.33 - 5.59) | Buy |
Bollinger Bands (100): | (4.82 - 6.06) | Buy |
ACST Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.01 | Sell |
Relative Strength Index (14 RSI): | 44.08 | Sell |
Chaikin Money Flow: | -5084 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (2.85 - 3.23) | Sell |
Bollinger Bands (100): | (2.81 - 3.39) | Sell |
AUPH Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 5.56 | Sell |
20-day SMA: | 5.5 | Sell |
50-day SMA: | 5.35 | Buy |
200-day SMA: | 6.81 | Sell |
8-day EMA: | 5.52 | Sell |
20-day EMA: | 5.49 | Sell |
50-day EMA: | 5.46 | Buy |
200-day EMA: | 6.64 | Sell |
ACST Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 2.98 | Sell |
20-day SMA: | 3.1 | Sell |
50-day SMA: | 2.92 | Sell |
200-day SMA: | 2.75 | Buy |
8-day EMA: | 2.97 | Sell |
20-day EMA: | 3.01 | Sell |
50-day EMA: | 3 | Sell |
200-day EMA: | 2.93 | Sell |
Aurinia Pharmaceuticals Earnings Growth & AUPH Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.20 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.65 per share, and an increase next year of $0.35 per share.
Acasti Pharma Earnings Growth & ACST Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.10 per share, an increase this year of $1.16 per share, and an increase next year of $0.30 per share.
Aurinia Pharmaceuticals Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Acasti Pharma Technical Analysis
Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | Jun 28 | Jul 1 | Jul 2 | Jul 3 | |
---|---|---|---|---|---|---|---|---|---|---|
Jun | Jul | |||||||||
20 | 21 | 24 | 25 | 26 | 27 | 28 | 01 | 02 | 03 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |